University of Montreal neuropsychology PhD student Émilie Delage, University of Quebec at Montreal professor of psychology and neuropsychology Isabelle Rouleau and University of Montreal…
IMAGE: Photobiomodulation tabletop device Beacon40 by neurotechnology company Bright Could flickering lights have brain health benefits? Research around experimental therapies involving external stimuli —…
The human body is host to trillions of microscopic organisms — collectively called the microbiome — that shape our health across the lifespan. This…
A recent cell study shows that experimental Parkinson’s and Alzheimer’s antibodies may trigger harmful brain inflammation—which could explain clinical trials’ dismal failure rates. In…
A recent analysis reveals that people with Alzheimer’s taking Alzheimer’s drug galantamine (Razadyne), approved nearly two decades ago, show moderate cognitive benefits as well…
In a new mice study, researchers showed that beta-amyloid — the toxic protein linked to Alzheimer’s — can gum up the olfactory system and…
With a strong family history of Alzheimer’s, Dewayne Nash had expected that he would start experiencing symptoms of the disease by the time he…
While drug developers are heads down in the lab working to find medical treatments to slow the progression of Alzheimer’s, one tech company is…
From the nature of Alzheimer’s to the solutions available for controlling it, here are five common misconceptions to dispel. Alzheimer’s is the sixth leading…
Early research shows that consistent use of saunas or hot tubs may offer similar health benefits to traditional aerobic exercise — including lowering a…
Scientists still don’t know why some people develop Alzheimer’s and others don’t. But while we may not fully understand the causes of Alzheimer’s, researchers…
Dementia-friendly communities, or age-friendly cities, are defined by the World Health Organization as places where healthcare, socializing and security are adapted to those in…
Since the novel coronavirus began raging across the world last year, scientists have come to understand that patients infected with SARS-CoV-2, the virus responsible…
Two first-of-their-kind studies presented at the Alzheimer’s Association International Conference show transgender and nonbinary adults are more likely show early possible signs of dementia….
In Being Patient’s LiveTalk series, Dr. David Weidman, associate medical director for research at the Banner Alzheimer’s Institute, shares insights on Eli Lilly’s investigational Alzheimer’s…